Haptoglobin Hp1 Variant Does Not Associate with Small Vessel Disease
Open Access
- 28 December 2019
- journal article
- research article
- Published by MDPI AG in Brain Sciences
- Vol. 10 (1) , 18
Abstract
Haptoglobin (Hp) is a plasma protein that binds free hemoglobin and protects tissues from oxidative damage. An Hp2 allele has been associated with an increased risk of cardiovascular complications. On the other hand, recent studies have suggested that Hp1 allele increases risk to develop severe cerebral small vessel disease. We aimed to replicate this finding in a first-ever stroke patient cohort. Hp was genotyped by PCR and gel electrophoresis in the Helsinki Stroke Aging Memory Study in patients with DNA and magnetic resonance imaging (MRI) available (SAM; n = 316). Lacunar infarcts and white matter lesions (WML) classified by Fazekas grading from brain MRI were associated with Hp genotypes. As population controls, we used participants of Cardiovascular diseases—a sub study of Health 2000 Survey (n = 1417). In the SAM cohort, 63.0% of Hp1-1 carriers (n = 46), 52.5% of Hp1-2 carriers (n = 141) and 51.2% of Hp2-2 carriers (n = 129) had severe WML (p = 0.372). There was no difference in severe WMLs between Hp1-1 vs. Hp1-2 and Hp2-2 carriers (p = 0.201). In addition, 68.9% of Hp1-1 carriers (n = 45), 58.5% of Hp1-2 carriers (n = 135), and 61.8% of Hp2-2 carriers (n = 126) had one or more lacunar lesions (p = 0.472). There was no difference in the number of patients with at least one lacunar infarct between Hp1-1 vs. Hp1-2 and Hp2-2 groups (p = 0.322). Neither was there any difference when diabetic patients (type I and II) were examined separately. Hp1 allele is not associated with an increased risk for cerebral small vessel disease in a well-characterized Finnish stroke patient cohort.Keywords
Funding Information
- Suomen Lääketieteen Säätiö (10000)
- Päivikki ja Sakari Sohlbergin Säätiö (10000)
- Helsinki and Uusimaa Research Grants (10000)
- Paavo Nurmen Säätiö (10000)
- Aarne Koskelon Säätiö (10000)
- Jane ja Aatos Erkon Säätiö (10000)
- Orionin Tutkimussäätiö (10000)
- Sigrid Juséliuksen Säätiö (10000)
- Paulon Säätiö (10000)
- Maire Taposen Säätiö (2500)
This publication has 27 references indexed in Scilit:
- Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegenerationThe Lancet Neurology, 2013
- Mechanisms of sporadic cerebral small vessel disease: insights from neuroimagingThe Lancet Neurology, 2013
- Complexity of a complex trait locus: HP, HPR, haemoglobin and cholesterolGene, 2012
- Biological, clinical and population relevance of 95 loci for blood lipidsNature, 2010
- Haptoglobin: Basic and Clinical AspectsAntioxidants & Redox Signaling, 2010
- Modeling of Environmental Effects in Genome-Wide Association Studies Identifies SLC2A2 and HP as Novel Loci Influencing Serum Cholesterol LevelsPLOS Genetics, 2010
- Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavengingBlood, 2009
- Haptoglobin Genotype Is a Regulator of Reverse Cholesterol Transport in Diabetes In Vitro and In VivoCirculation Research, 2006
- Magnetic Resonance Imaging White Matter Hyperintensities and Mechanism of Ischemic StrokeStroke, 1999
- Effect of Haptoglobin Subtypes on Serum Lipid LevelsHuman Heredity, 1987